Baltimore, Maryland — Shimadzu Corporation announced today the release of the new mutual support between the Skyline quantitative proteomics software and Shimadzu’s high sensitivity triple quadrupole LC/MS/MS platform. As mass spectrometry-based proteomics technologies continue to play an ever-increasing role in biomarker discovery, validation and translation for biological and clinical applications, advances in throughput and multiplexing […]
SUNNYVALE, Calif. — Cepheid (NASDAQ: CPHD) today announced the release of Xpert? Carba-R, an on-demand molecular test for rapid and accurate detection of carbapenemase-producing Gram-negative bacteria, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid’s GeneXpert? System, the world’s leading molecular […]
BALTIMORE –– Thermo Fisher Scientific today announced that its San Jose, California facility has registered with the U.S. Food and Drug Administration (FDA) as a medical device establishment. The site has established a quality in accordance with the FDA Quality System Regulations to design and manufacture devices for analyzing samples from patients for in vitro […]
Cambridge, UK — Horizon Discovery™ Group plc (LSE: HZD) (Horizon), the international life science company supplying research tools to organizations engaged in genomics research and the development of personalized medicines, today announces, together with LGC, an international life sciences measurement and testing company, that they have been offered a research grant of £360,224 ($608,000 USD) […]
Brisbane, CA — CareDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients,today announced that it has entered into a multi-year supply agreement with Illumina, Inc. that will provide access to next generation sequencing, microarray equipment and consumables to the CareDx reference […]
LUXEMBOURG — Advanced Biological Laboratories (ABL), S.A., announces the signing of a licensing and collaboration agreement with Tute Genomics. ABL is also pleased to announce the commercial launch of OncoChek™ for managing and analysing genomics data in the field of oncology. “With the continuous pipeline of new features appearing in the Tute Genomics platform including […]
Biocartis and Abbott Announce Exclusive Partnership to Develop Multiplex Companion Diagnostics Tests
Mechelen, Belgium and Abbott Park, Ill.-– Biocartis and Abbott today announced a collaboration to develop and commercialize companion diagnostics tests. Under the agreement, the companies will leverage Biocartis’ molecular diagnostics system, Idylla™, and Abbott’s regulatory, scientific and commercialization expertise. “Much of the current molecular diagnostic practice involves a series of specialized, labor intensive and time-consuming […]
Gardner, MA.-– Today, New England Peptide, Inc. (NEP) and SISCAPA Assay Technologies, Inc. (SAT) announced a collaboration for the manufacture and sale of Stable Isotope Standard (SIS) peptides for use in SISCAPA® protein quantification assays. Under the terms of the agreement, NEP will manufacture peptide standards suitable for use with SAT’s SISCAPA assays. The peptides […]
Baltimore, MD — BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its launch of the BD BACTEC™ FX40 Blood Culture System with connectivity to the BD EpiCenter™ Microbiology Data Management System. This communication enables access to advanced reporting capabilities, connectivity to the hospital’s […]
HERCULES, CA –— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products announces that it has extended its contract with Premier, Inc., one of the largest group purchasing organizations based in the U.S. The agreement includes Premier general level and ASCEND members. Premier initially […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
